Liquid biopsies in precision oncology for older adults with cancer
As the global population ages, innovative strategies for cancer management in older adults are urgently needed. Liquid biopsy, a non-invasive tool, offers great promise for this demographic by enabling early detection, real-time monitoring, and therapeutic target identification. This review highlights the clinical utility, feasibility, and safety of liquid biopsies in geriatric oncology, emphasizing their potential integration into routine care to improve treatment outcomes and quality of life for older patients.
Authors
- Jennifer Nobes (ORCID: https://orcid.org/0009-0009-9198-2698)
- C. Falandry
- Jaime O. Herrera‐Cáceres (ORCID: https://orcid.org/0000-0001-6793-4404)
- Nicolò Matteo Luca Battisti (ORCID: https://orcid.org/0000-0002-1063-1717)
- Kian Ping Loh (ORCID: https://orcid.org/0000-0002-1491-743X)
- Zicheng Lyu
- Nina Rosa Neuendorff (ORCID: https://orcid.org/0000-0001-8518-3616)
- Marcus Vetter (ORCID: https://orcid.org/0000-0002-1785-4876)
- Valentin Goede
- Yue Zhao
- Hans Wildiers
- Beverly Canin
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Oklahoma State Department of Health (US)
- City Of Hope National Medical Center (US)
- Inserm (FR)
- Rochester Institute of Technology (US)
- Royal Free London NHS Foundation Trust (GB)
- Ninewells Hospital (GB)
- Universitätsklinik Marien Hospital Herne (DE)
- Hospices Civils de Lyon (FR)
- Psychiatry Baselland (CH)
- City of Hope (US)
- Hôpital Lyon Sud (FR)
- St. Marien Hospital (DE)
- Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition (FR)
- University Hospital Cologne (DE)
- KU Leuven (BE)
Publication Details
- Journal
- npj Precision Oncology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1038/s41698-026-01285-5
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00